Jins Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3386110005
JPY
5,560.00
-140 (-2.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

276.8 k

Shareholding (May 2015)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 26.92%

  • Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 37.65
2

The company has declared Positive results for the last 8 consecutive quarters

3

With ROCE of 46.34%, it has a attractive valuation with a 8.74 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 211,983 Million (Small Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.15

stock-summary
Return on Equity

28.13%

stock-summary
Price to Book

7.20

Revenue and Profits:
Net Sales:
24,983 Million
(Quarterly Results - May 2025)
Net Profit:
2,500 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-43.27%
0%
-43.27%
6 Months
-35.5%
0%
-35.5%
1 Year
-11.46%
0%
-11.46%
2 Years
33.17%
0%
33.17%
3 Years
18.3%
0%
18.3%
4 Years
-14.85%
0%
-14.85%
5 Years
-17.51%
0%
-17.51%

Jins Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.70%
EBIT Growth (5y)
4.46%
EBIT to Interest (avg)
44.88
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
2.26
Tax Ratio
31.40%
Dividend Payout Ratio
30.48%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
29.40%
ROE (avg)
15.81%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
7.15
EV to EBIT
18.85
EV to EBITDA
14.74
EV to Capital Employed
8.74
EV to Sales
2.19
PEG Ratio
0.19
Dividend Yield
NA
ROCE (Latest)
46.34%
ROE (Latest)
26.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : May 2015stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24,983.00",
          "val2": "21,056.00",
          "chgp": "18.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,498.00",
          "val2": "2,692.00",
          "chgp": "67.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.00",
          "val2": "35.00",
          "chgp": "-42.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.00",
          "val2": "-1.00",
          "chgp": "-1,000.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,500.00",
          "val2": "1,317.00",
          "chgp": "89.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "149.60%",
          "val2": "95.20%",
          "chgp": "5.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2024 is 13.29% vs 9.51% in Aug 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2024 is 165.10% vs 134.93% in Aug 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Aug'24",
        "Aug'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "82,999.00",
          "val2": "73,264.00",
          "chgp": "13.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10,763.00",
          "val2": "7,765.00",
          "chgp": "38.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "129.00",
          "val2": "141.00",
          "chgp": "-8.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-773.00",
          "val2": "-575.00",
          "chgp": "-34.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,671.00",
          "val2": "1,762.00",
          "chgp": "165.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.40%",
          "val2": "66.20%",
          "chgp": "2.82%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - QoQstock-summary
May'25
Nov'24
Change(%)
Net Sales
24,983.00
21,056.00
18.65%
Operating Profit (PBDIT) excl Other Income
4,498.00
2,692.00
67.09%
Interest
20.00
35.00
-42.86%
Exceptional Items
-11.00
-1.00
-1,000.00%
Consolidate Net Profit
2,500.00
1,317.00
89.83%
Operating Profit Margin (Excl OI)
149.60%
95.20%
5.44%
USD in Million.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Aug'24stock-summary
Aug'24
Aug'23
Change(%)
Net Sales
82,999.00
73,264.00
13.29%
Operating Profit (PBDIT) excl Other Income
10,763.00
7,765.00
38.61%
Interest
129.00
141.00
-8.51%
Exceptional Items
-773.00
-575.00
-34.43%
Consolidate Net Profit
4,671.00
1,762.00
165.10%
Operating Profit Margin (Excl OI)
94.40%
66.20%
2.82%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Aug 2024 is 13.29% vs 9.51% in Aug 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Aug 2024 is 165.10% vs 134.93% in Aug 2023

stock-summaryCompany CV
About Jins Holdings, Inc. stock-summary
stock-summary
Jins Holdings, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available